Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2003
12/31/2003WO2004000301A1 Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether
12/31/2003WO2004000293A2 Use of taurine or derivatives thereof for the treatment of alopecia
12/31/2003WO2004000291A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails
12/31/2003WO2004000271A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis
12/31/2003WO2004000245A1 Promoter for uptake of basic amino acid into cell and cosmetic or drug composition
12/31/2003WO2004000237A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003WO2004000230A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
12/31/2003WO2004000227A2 Use of thio-oxindole derivatives in treatment of skin disorders
12/31/2003WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
12/31/2003WO2003086460A3 High fluence rate activation of photosensitizers for dermatological applications
12/31/2003WO2003082372A3 Chemiluminescent treatment of acne
12/31/2003WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/31/2003WO2003075901A3 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
12/31/2003WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/31/2003WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2003006492A3 Biologically active peptides
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002070068A3 Lipoxin analogs as novel inhibitors of angiogenesis
12/31/2003WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/31/2003WO2002055075A3 Compounds and methods for regulating cell differentiation
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2001006984A3 Small molecules useful in the treatment of inflammatory disease
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1463743A Capsule possessing antisenescent and spot dispelling effect and method for making the same
12/31/2003CN1463742A Pudendum nursing liquid containing extract of oceanic organism
12/31/2003CN1463740A A medicine for treating bed-sore and method for preparing same
12/31/2003CN1463738A A medicine for treating scald and burn, and method for preparing same
12/31/2003CN1463728A Medicine for saprophage removing and muscle growing and method for preparing the same
12/31/2003CN1463713A External use medicine liquid for treating scald
12/31/2003CN1132618C Medicine for treating skin ulcer
12/31/2003CN1132603C Compound Wuduqing capsule of blister beetle
12/31/2003CN1132587C Preparation method of medicine for curing surgical diseases of traditional Chinese medicine
12/31/2003CN1132583C Medicine for treating foot ringwoorm
12/31/2003CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2490516A1 Honey-based skin care preparation
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2489815A1 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
12/31/2003CA2489810A1 Use of thio-oxindole derivatives in treatment of skin disorders
12/31/2003CA2489614A1 Oral preventive or therapeutic agent for skin damage containing diacylglyceryl ether
12/31/2003CA2489308A1 Use of taurine for the treatment of alopecia
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670469 Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof
12/30/2003US6670455 Use of a chromatography separation processes and/or fractional precipitation
12/30/2003US6670396 Aspirin-triggered lipid mediators
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670354 Methods to enhance white blood cell count
12/30/2003US6670333 Providing exogenous antiangiogenic protein to endothelial cells associated with said tissue
12/30/2003US6670164 Isolated human kinase proteins
12/30/2003US6670138 Method of diagnosing ischemic stroke via UCP-2 detection
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2338325C Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
12/30/2003CA2273960C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
12/30/2003CA2144416C Method and composition for the treatment of hair loss
12/30/2003CA2080555C Bis(phenyl)ethane derivatives
12/25/2003WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236299 Promoting biosynthsis of collagen; collagenase inhibitors; topical applying to skins
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
12/25/2003US20030236281 Quinoline derivatives(2)
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease
12/25/2003US20030236248 Kappa agonist compounds and pharmaceutical formulations thereof
12/25/2003US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2
12/25/2003US20030236182 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
12/25/2003US20030235888 Therapy for bone defects
12/25/2003US20030235626 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
12/25/2003US20030235611 Vesicle comprises ATP and phospholipid; fusion proteins
12/25/2003US20030235601 Insect repellent compounds
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/25/2003US20030235584 Method for preparing anti-MIF antibodies
12/25/2003US20030235541 Topical administration of basic antifungal compositions to treat fungal infections of the nails
12/24/2003WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003WO2003106507A1 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions
12/24/2003WO2003106506A1 Low molecular weight oversulfated polysaccharide
12/24/2003WO2003106505A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
12/24/2003WO2003106504A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
12/24/2003WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003WO2003106456A2 New compounds
12/24/2003WO2003106441A1 Pharmaceutical salts of reboxetine
1 ... 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 ... 1065